ArticlePalliative care and social practice2026
Assessment of the use of the Edmonton Symptom Assessment Scale - Revised (ESAS-r) among hospitalised patients with limited life expectancy: A cross-sectional study.
Article in Palliative care and social practice, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Palliative care aims to improve the quality of life for patients with advanced chronic diseases. Accurate symptom assessment, based on fully completed questionnaires, is essential for selecting appropriate treatments during the final stages, when patients experience severe distress. Objectives: This study evaluates the use of the Edmonton Symptom Assessment Scale - Revised (ESAS-r) in hospitalized patients with limited life expectancy. Design: This cross-sectional study included hospitalized patients with advanced chronic diseases and a life expectancy of less than six months, as determined by the healthcare team's clinical judgment using the Surprise Question at admission. Methods: The ESAS-r, a validated brief self-report tool, was used to assess nine core symptoms and one additional symptom: pain, tiredness (lack of energy), nausea, drowsiness, lack of appetite, shortness of breath, depression (feeling sad), anxiety (feeling nervous), overall well-being, and an optional symptom. If the patient's condition permitted, the investigator administered the questionnaire verbally and recorded the responses. If not, the reason was documented, and patient data were collected. Results: The ESAS-r effectively captured a multidimensional profile of patient suffering. Depression, impaired well-being, and tiredness were the most severe symptoms reported. However, 45% of patients (n = 47/104) with significantly lower Karnofsky Performance Scale (KPS) scores were unable to complete the study due to poor general condition. Patients who died within six months had significantly higher rates of cancer (p = 0.016) and more severe appetite loss (p = 0.010) than survivors. Conclusion: The ESAS-r is an effective tool for monitoring both physical and psychological symptoms in hospitalized palliative patients. Among patients with limited life expectancy and poor functional status, nearly half may be unable to complete the questionnaire due to their condition.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.